课题基金 / 基金详情

Malaria Parasite Ligands And Host Cell Receptors

Malaria Parasite Ligands And Host Cell Receptors
疟疾寄生虫配体和宿主细胞受体
批准号:
6807878
负责人:
Louis Miller
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Louis Miller的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Purpose: 1. To identify the receptors on malaria parasites for red cell invasion and on infected red cells for adhesion to endothelium and to placenta. 2. To identify the red cell receptors for each parasite ligand. 3. To identify the minimal domain in the variant antigen for binding to placenta. 4. Test a region on the variant antigen for inducing protection against P. falciparum in Aotus monkeys and for overcoming variation. Accomplishments during the year: 1. Six mutations were identified worldwide in one of the P. falciparum parasite receptor. Each mutation binds to a different receptor on the red cell. The parasite receptor for other members of this family are shown to bind red cells 2. The minimal domain on the variant antigen for binding chondroitin sulfate A in placenta has been identified. As the binding of infected red cells in placenta is associated with fetal and newborn mortality, blocking this with a vaccine may reduce disease. Antibodies to this domain appear to be cross- reactive to parasites from around the world. We are working on this domain as a vaccine candidate. 3. A method has been developed to induce immunity that will overcome diversity in the variant antigen.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MALARIA VACCINE DEVELOPMENT UNIT (MVDU)
Malaria Parasite Ligands And Host Cell Receptors
Malaria Vaccines: BSAM-1/ALHYDROGEL + CPG 7909
Malaria Vaccines: AMA1-C1/ISA 720
海外基金